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Abstract
Home health care is a method of medical care that patients
receive inside their home under the supervision of a collaborative team of physicians, nurses, pharmacists and sometimes other health care professionals. Home health provides
patients with the same standard of care that they would be
receiving in a nursing home or hospital. However, the treatment and continued monitoring at home reduces health care
costs and makes the patient feel more comfortable. Pharmacists analyze, resolve and prevent medication-related
problems in home health care in order to minimize hospitalizations and improve patient quality of life. Pharmacist
involvement with other health care professionals in the
patient transition of care can help maximize the quality of
patient care. To become a home health care pharmacist,
neither a residency nor certification is required. Home health
pharmacists perform medication reconciliation, comprehensive medication reviews, monitor intravenous drug therapy
and enteral therapy, identify high-risk medications and adverse drug reactions, prevent polypharmacy and improve
patient adherence. Patients that must be fed through enteral
nutrition tubes in the home health care setting have a set of
special concerns that the home health care team must
address. Pharmacists' extensive knowledge of medication
necessitates their involvement on the home health care team.
Key Terms
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Role of the Home Health Care Pharmacist
Patients receiving home health care frequently rely on their
p ersonal financial a ssets, such as their ability to afford medications and persc>nal health aid, as well as their level of
health literacy to manage their medications and health.1 This
unstructured environment may lead to undesirable medication problems w hich may interfere with the goals of therapy.
One of home health care's biggest roles is to prevent the use
of unnecessary and duplicate medications or the omission of
prope r drugs.2 In addition, patients may be using inappropriate doses and possibly experiencing drug-drug interactions.
Each of these issues provides an opportunity for the home
health care pharmacist to assist in patient care. Currently,
neither a residency nor certification is required for this specialty.3 In the home hea.lth care environment pharmacists
perform medication reconciliation to identify and prevent
complications. These complications could be due to drugdrug interactions o r unnecessary medications which can be
identified by comparing a patient's medical records to hospital admissions, transitions of care and discharge orders.4
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Typically, a home health pharmacist may visit or interact
with at least five patients each day for about 30 to 60
minutes.2 The patient-pharmacist meeting may be conducted
in several ways including telephone interviews, home health
visits, chart reviews or a combination of each. Prior to the
appointment, the home health pharmacist examines the patient's information and performs a comprehensive medication review to include all prescriptions, over-the-counter
medications and any dietary or herbal supplements. During
the appointment, the pharmacist and patient discuss the appropriate indications for current medications as well as the
safety and efficacy of these medications. The pharmacist also
assesses the patient's adherence and compliance to the suggested therapeutic plan. The pharmacist is required to
properly document all of the current medications, health
conditions and medication-related problems discussed with
patients during these meetings. The patient-pharmacist
meeting provides a great opportunity for pharmacists to be
personally involved with their patients and allows them to
detect any issues earlier and more readily.
According to an abstract from a study done by Lipton et al.,
out of 236 ambulatory care patients that were 65 years of
age and above, 88 percent presented with at least one clinically significant medication problem.s This is an opportunity
for pharmacists to encourage and aid other health care workers in employing evidence-based prescribing for all patients,
with special consideration for those at home.6 As a result, the
number of medication problems can decline to hopefully decrease overall patient mortality and medical costs. Additionally, pharmacists can aid in the adjustment of medication
regimens and treatment to patient's learning ability, which is
especially important for those receiving health care at home.
This involves assessing a patient's reading level, ability to
comply with medication regimens and understanding of
medication administration and safety, all of which can be
done by a home health care pharmacist.
Home Health Pharmacist Assistance in Transitions of
Care
According to Hester et al., almost two-thirds of medication
errors happen during transitions of care into the home
health setting, and approximately one in five older patients
are readmitted within one month after hospital discharge
due to a preventable medication error.4 Common medication
classes that cause these readmissions include anti-infective,
cardiovascular, central nervous system, endocrine and hematologic medications, with the most problematic medications
being oral antiplatelets, oral hypoglycemics, insulin and warfarin. Starting in 2012, these preventable hospital readmissions are being monitored by the Centers for Medicare and
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Medicaid Services (CMS), which monetarily penalizes hospitals for high readmission rates.
One way to improve the transition of care is for pharmacists
to continually perform medication reconciliations, during
which they analyze the patient's medications to avoid drug
interactions, duplicative therapies or indication errors. 4
Imp roving the communication between home health,
community and hospital-based pharmacists can also help
clarify questions and identify medication discrepancies.
Additionally, pharmacists in all settings can aid in the transition of care by keeping an open line of communication with
the physicians and nurses that are treating the patient.

Enteral Nutrition
Enteral nutrition (EN) is utilized to improve quality of life
through the prevention and treatment of malnutrition and
improve growth in children, while also aiding in the treatment of chronic gastrointestinal disease states such as
Crohn's disease.7 Several chronic disease states such as dementia, cystic fibrosis, peritoneal dialysis, oro-pharyngeal
and esophageal malignancy and amyotrophic lateral sclerosis
(ALS) can also benefit from home-health monitoring. Diseases such as Crohn's disease, pancreatitis and ulcerative colitis
may require patients to be put on feeding tubes for nutritional support.7.B Feeding tubes assist patients by retaining hydration (decreasing the possibility of aspiration or choking),
managing weight as well as preserving energy.a For patients
with a functioning gastrointestinal (GI) tract, EN is preferred
over total parenteral nutrition (TPN). In contrast to TPN
which is administered intravenously, EN utilizes a feeding
tube directly placed in the GI tract. As a result, the overall risk
of infection is decreased, providing better patient outcomes.
Enteral nutrition involves the administration of a formulated
liquid, also known as medical food, to help the distinct
dietary needs for a patient's particular disease state or condition.9 These formulations contain fats, carbohydrates, vitamins, proteins and minerals to exceed 1,3 50 kilocalories a
day. Enteral nutrition should be considered when nutrition
and hydration are insufficient, dysphagia and aspiration occur frequently or weakness and weight loss lead to decreased energy.a Contraindications to EN use include active
coagulopathies, thrombocytopenia, sepsis, peritonitis, ascites, anorexia and pyloric obstruction.7 Part of the pharmacist's role in patients with feeding tubes is to ensure that the
patient's daily nutritional needs are met and successfully
coincide with their medication needs without interactions.10
Although EN provides great benefits for patients, some may
fear having a surgical procedure to implant the tube or the
possibility of infection or pain at the insertion site.a Before a
patient is placed on EN, a health care professional must ensure that the patient and their caregivers are capable of implementing this therapy.11 Ongoing medical supervision is
necessary for those receiving EN products in order to avoid
complications. This supervision includes the assessment of
patient motivation, financial status, educational ability, nutritional and medical benefit, physical limitations and capacity
to adhere to safety standards. This is an area in which home
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health pharmacists are needed to maintain an open flow of
communication between health care members, as well as to
properly educate patients on EN administration, how to administer medications while utilizing a feeding tube and common complications that may arise with both EN feedings and
medication administration through the tubes.

Enteral Feeding Tube Selection and Administration
There are many important considerations when a patient is
enterally fed. The type of feeding tube to be used is determined by the patient's disease state and the severity of their
condition as well as the length of time that they will need to
receive tube feeding. 1 2 Nasoenteric tubes are most often used
for short-term (one to three weeks) nutritional support due
to their low cost and easy insertion through the nose directly
into the GI tract. These include nasogastric (NG) and nasoduodenal (ND) as well as nasojejunal (NJ) tubes. Orogastric
(OG) tubes are also used for short-term feeding and are inserted through the mouth into the stomach. Orogastric tubes
are used for short-term feeding when the tube cannot
properly be placed nasally due to injury, deviated septum or
sinusitis. For long-term (four to six weeks or more) tube
feeding, the tubes are surgically placed directly from the outside of the body into the stomach or intestine, bypassing the
upper part of the GI tract. The most commonly used tube is
the percutaneous endoscopic gastrostomy (PEG)-tube because of its relatively easy method of placement.
Nutrition support via enteral feeding can be provided i .1
different ways depending on the type of tube and patier.c's
condition. Feedings can be continuous, cyclic, bolus or i 1termittent.12 Continuous feeding over a 24-hour perior is the
preferred method for the initiation of EN therapy ir critically
ill patients due to the constant administration r, nutrients.
However, continuous feedings are commonl.1 interrupted
when patients need to take their medication·,, Cyclic feedings
are a continuous supply of nutrients over ·.n eight to 20 hour
period and typically take place throug~.out the night when
the patient is sleeping. Bolus feedings JCCur four to six times
per day to allow the nutrients to infr .>e over a short time period at specified intervals. This r ,ethod is convenient for
health care professionals to admir .1ster medications between
nutrient feedings. In this circumf .:ance, EN should be stopped
30 minutes before giving the medications to allow gastric
emptying. Then, EN may be started 30 minutes after the
medication is given which a· wws time for absorption. Intermittent feeding is similar .o bolus feeding but used over a
longer duration. Continr Jus and cyclic feedings are preferred when feeding ir .:o the stomach or small intestine,
whereas bolus and int .rmittent feedings are generally used
only in the stomach ; nd not in the small intestine. Feeding
tubes sizes are typic .lly small-bore (5 to 12 French units) or
large-bore (14 or rr 0re French units) where 1 French unit is
equivalent to 0.3? mm. Both small and large bore tubes are
used for percutr neous routes into the stomach and small
intestine. In cor .:rast smaller bore tubes are more commonly
used for nasal i outes and larger tubes for oral routes. Smaller
tubes are generally more comfortable than larger tubes.
However, they become clogged more easily by thick nutrition
formulations or medications administered through the tube.
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It is very important to avoid tube occlusions, or blockages,
because they prevent the patient from receiving their proper
nutrients and medications. Regardless of the dosage form
used, the tube needs to be flushed with about 30 mL of sterile
water before and after medication administration to help
prevent occlusions.13 In addition to flushing and irrigation,
patients may be given a prophylactic dose of alkalinized enzyme solution with a pH of 7.9 to prevent occlusion. 12 This
solution typically consists of one crushed pancrelipase tablet
(lipase 8,000 units, amylase 30,000 units, protease 30,000
units) mixed with one crushed sodium bicarbonate tablet
(324 mg) which is then dissolved in 5 mL of warm water. The
administration of alkalinized enzyme solution may also be
used to try to unclog an occluded tube.
Medication Considerations for Patients on Feeding Tubes
Patients receiving feeding tube nutrition require special considerations for the administration of medications due to the
underlying disease state inhibiting the patients' ability to
take drugs orally.12.13 Drug absorption for patients on EN is
affected by the dosage form of the medication as well as the
placement of the feeding tube.12 For instance, some oral medications can be crushed and given through feeding tubes,
conveniently depositing the medication directly into the patient's GI tract. However, some oral medications may not be
crushed for administration due to their coatings because the
medication will not have extended release properties and,
therefore, it will not absorb correctly (i.e., acetaminophen,
ferrous sulfate, omeprazole).13 Nonetheless, liquid formulations of some of these medications are available, solving this
issue. Possible interactions may also exist between the drug
and the compounds in the nutrition regimen (i.e., phenytoin,
carbamazepine, warfarin).12.13 Delayed and extended release
tablet coatings may not be crushed due to their release characteristics; if the coating is broken, the drug will not be administered the way in which it was intended. Instead, all of
the drug would be released/absorbed at once rather than
delayed or extended over time. In addition to the properties
of the drug itself, it is also important to make sure that the
drug formulation is able to physically pass through the tube
and into the GI tract without causing an occlusion or damaging the tube. If any of these interactions or occlusions occur,
the patient will not receive the proper dose of the drug.
In addition to solid dosage forms, several other oral dosage
forms may be administered through the EN tube.12 Liquid
preparations are preferred because they are readily absorbed, do not have to be crushed, and are less likely to cause
tube occlusions. Suspensions and elixirs are preferred over
syrups because of their decreased viscosity. The tonicity, osmolality and sorbitol content of liquid preparations should
be closely monitored to prevent adverse events such as diarrhea, bloating, nausea or cramping. Solutions may be diluted
with sterile water if necessary. Liquid-filled capsules are also
able to be administered enterally, and in most cases the capsule may be dissolved and all contents can be put through the
tube. Capsules that contain beads or powders may be broken
so that only the beads or powders may pass through the EN
tube.
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When considering drug absorption issues due to the placement of the feeding tube, the pharmacist has to examine the
pharmacokinetics of the particular medication.12-14 Most
medications are typically absorbed in the small intestine, but
some drugs such as antacids, sucralfate and bismuth have
actions in the stomach.12.13 If a patient has a feeding tube
placed in the small intestine but needs a drug that acts in the
stomach, the administration of the drug through their intestinal feeding tube will have minimal effects. Another example
of this involves ketoconazole and itraconazole. In order for
these medications to be properly absorbed, they must
interact with the acidic gastric environment. However, if the
feeding tube is in the small intestine, these drugs will have
decreased bioavailability due to the absence of interaction
with the stomach environment. Another consideration
should be taken into account for drugs such as opioids, tricyclic antidepressants, beta-blockers and nitrates that undergo
extensive first-pass hepatic metabolism. If these drugs are
administered through a feeding tube that deposits into the
jejunum, their absorption will increase leading to greater
systemic effects. It is extremely important for pharmacists to
check drug compatibility with the placement of the tube for
home health patients to avoid changes in drug absorption/
bioavailability.
Medications generally should not be coadministered with the
nutrition formulation, with the exception of any necessary
electrolyte supplements.12 Combining the medication with
the nutrition formulation will increase the probability for a
drug-nutrient interaction, alteration of the bioavailability of
the medication, occurrence of tube occlusions and potential
microbial contamination. Pharmacists should be knowledgeable of possible drug-nutrient interactions causing reduced
medication bioavailability.10 For example, the effectiveness of
antimicrobials such as levofloxacin, ciprofloxacin and moxifloxacin can be decreased by calcium, magnesium and iron
during tube feeding.12 Also, enteral feeding should be held
one to two hours before and after the administration of either phenytoin or warfarin to avoid decreased bioavailability
of these medications caused by binding to the protein component of the medical food. Although medical food formulations are compatible with some medications, it is necessary
to check package inserts or drug information sources to ensure the safety of concurrent administration of a medication
with EN.
Patients with enteral feeding needs that are on medications
present a very important area of concern for the home health
pharmacist-the drug expert of the home health team. Each
medication the patient is taking should be evaluated by the
pharmacist to determine how it needs to be administered, if
there are any absorption issues due to the EN and if there are
any possible interactions between the medications and nutrition regimen. 12.13 A comprehensive list of medications that
cannot be crushed is available from the Institute for the Safe
Use of Medications at www.ismp.org/tools/donotcrush.pdf.
Additionally, pharmacists can refer to the package insert of
specific medications using drug information sources such as
Clinical Pharmacology, Lexicomp®, Micromedex® or Facts &
Comparisons®. Alternative routes of administration, such as
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intravenous infusions and intramuscular injections as well as
transdermal patches and sprays, must be considered for
medications that cannot be given through the tube.12 In these
instances, pharmacists may also consider finding a different,
therapeutically equivalent medication that can be administered through an enteral tube.

Pain Symptom Manage [Internet]. 1999 Mar [cited 2014 Oct 5]; 17(3):
197-207. Available from : www.sciencedirectcom/science/article/pii/
S0885.
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Conclusion
The growing use of EN in home health requires home health
pharmacists to become more involved in patient care. On the
home health care team, physicians are responsible for
prescribing medications, while nurses are responsible for
administering them to the patients. Pharmacists, as drug
experts, are able to maximize medication therapies for EN
patients through ensuring that medications are administered
in the proper dosage form, and that there is little to no risk of
drug interactions. In order to have the best outcomes for
home health EN patients, pharmacists must work with other
health care providers to decrease medication -related errors,
reduce feeding tube complications and provide a better quality of life for each patient.
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